The in vivo susceptibility of Leishmania donovani to sodium stibogluconate is drug specific and can be reversed by inhibiting glutathione biosynthesis

K.C. Carter, S. Sundar, C.M. Spickett, O.C. Pereira, A. Mullen

Research output: Contribution to journal › Article › peer-review

52 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The in vivo susceptibility of Leishmania donovani to sodium stibogluconate is drug specific and can be reversed by inhibiting glutathione biosynthesis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology